Minotrex (Minocycline Hydrochloride)

Minotrex, a tetracycline‑class antibacterial, is indicated for bacterial infections affecting the skin, respiratory system, and pilosebaceous units.

• Acne vulgaris: reduces inflammatory lesions and bacterial colonisation of the skin.
• Skin and soft tissue infections: eradicates susceptible Gram‑positive and Gram‑negative organisms causing cellulitis, abscesses, and wound infections.
• Respiratory tract infections: treats community‑acquired pneumonia, sinusitis, and bronchitis caused by susceptible bacteria.

• Minocycline Hydrochloride inhibits bacterial protein synthesis by binding to the 30S ribosomal subunit, blocking the attachment of aminoacyl‑tRNA to the mRNA‑ribosome complex. This action prevents elongation of the nascent peptide chain, leading to bacteriostatic activity against a broad spectrum of susceptible microorganisms.

Minocycline may cause a range of adverse reactions, from mild to severe.

Common Side Effects

• Nausea or vomiting: gastrointestinal upset occurring shortly after dosing.
• Diarrhea: loose stools that may be mild to moderate in intensity.
• Photosensitivity: increased skin sensitivity to sunlight, leading to sunburn‑like reactions.
• Dizziness or vertigo: transient balance disturbances, especially when standing quickly.

Serious or Rare Side Effects

• Hypersensitivity reactions: rash, Stevens‑Johnson syndrome, or anaphylaxis requiring immediate medical attention.
• Drug‑induced lupus erythematosus: systemic autoimmune manifestations such as arthralgia, fever, and serologic abnormalities.
• Hepatic injury: elevated liver enzymes or clinically apparent hepatitis, which may necessitate discontinuation.

Before initiating Minotrex, clinicians should consider several safety measures.

• Renal or hepatic impairment: assess function and adjust therapy if necessary.
• Known tetracycline allergy: avoid use to prevent hypersensitivity.
• Pregnancy and lactation: evaluate risk versus benefit, as safety data are limited.
• Sun exposure: advise patients to use protective clothing and sunscreen.
• Long‑term therapy: monitor for pigmentary changes in skin or teeth.

Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Minotrex can alter the activity of several concomitant medicines.

Major Interactions (Avoid)

• Isotretinoin: combined use may increase risk of intracranial hypertension.
• Warfarin: potentiates anticoagulant effect, raising bleeding risk.
• Antacids containing aluminum, calcium, or magnesium: markedly reduce minocycline absorption.

Moderate Interactions (Monitor Closely)

• Oral contraceptives: may reduce contraceptive efficacy, requiring additional birth control methods.
• Penicillins or cephalosporins: potential antagonism reducing antibacterial effectiveness.
• Retinoids: may enhance risk of pseudotumor cerebri when used together.